TNF and breast carcinoma: Of note, 1,25(OH)2D3 treatment protects against TNF-α-induced VDR loss, suppresses TGF-β1-promoted increase in the migration capacity of cultured breast cancer cells, and inhibits lung metastasis in an orthotopic breast cancer mouse model [43].